BridgeBio Pharma, Inc.
US ˙ NasdaqGS ˙ US10806X1028

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Neil Kumar. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Neil Kumar har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:BBIO / BridgeBio Pharma, Inc. Chief Executive Officer, Director 875.686
US:LIAN / LianBio - Depositary Receipt (Common Stock) Director 5.002.792
Chief Executive Officer, Director, 10% Owner 24.575.501
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Neil Kumar. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BBIO / BridgeBio Pharma, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BBIO / BridgeBio Pharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BBIO / BridgeBio Pharma, Inc. Insider Trades
Insidersalg BBIO / BridgeBio Pharma, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BBIO / BridgeBio Pharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-12-21 BBIO Kumar Neil 200.000 200.000 7 6.7400
2022-11-17 BBIO Kumar Neil 34.640 9,3997 34.640 9,3997 325.606

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BBIO / BridgeBio Pharma, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Neil Kumar som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -800 875.686 -0,09 53,80 -43.040 47.111.381
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -16.900 876.486 -1,89 53,16 -898.450 46.596.362
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2.300 893.386 -0,26 51,96 -119.514 46.422.570
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -900 4.678.447 -0,02 53,80 -48.424 251.721.034
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -16.800 4.679.347 -0,36 53,16 -893.125 248.764.381
2025-09-08 2025-09-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2.300 4.696.147 -0,05 51,95 -119.496 243.986.439
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5.442 895.686 -0,60 51,85 -282.187 46.444.454
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14.558 901.128 -1,59 51,16 -744.739 46.098.735
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5.475 4.698.447 -0,12 51,85 -283.902 243.634.680
2025-09-08 2025-09-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -14.525 4.703.922 -0,31 51,15 -742.960 240.607.492
2025-08-22 2025-08-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -428 223.090 -0,19 49,25 -21.079 10.987.272
2025-08-22 2025-08-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -25.728 223.518 -10,32 48,81 -1.255.848 10.910.472
2025-08-19 2025-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -32.855 249.246 -11,65 51,32 -1.686.119 12.791.305
2025-08-19 2025-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 64.697 282.101 29,76
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8.205 915.686 -0,89 46,71 -383.252 42.771.327
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8.205 915.686 -0,89 46,71 -383.252 42.771.327
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11.795 923.891 -1,26 45,88 -541.162 42.388.673
2025-08-11 2025-08-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11.795 923.891 -1,26 45,88 -541.162 42.388.673
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13.216 935.686 -1,39 45,64 -603.152 42.702.838
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -13.216 935.686 -1,39 45,64 -603.152 42.702.838
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6.784 948.902 -0,71 45,09 -305.909 42.788.553
2025-08-11 2025-08-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6.784 948.902 -0,71 45,09 -305.909 42.788.553
2025-07-03 2025-07-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20.000 955.686 -2,05 42,73 -854.514 40.832.353
2025-07-03 2025-07-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20.000 4.758.447 -0,42 42,73 -854.536 203.313.213
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1.600 975.686 -0,16 42,89 -68.628 41.849.612
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -18.400 977.286 -1,85 42,50 -782.092 41.539.541
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1.700 4.778.447 -0,04 42,88 -72.903 204.919.399
2025-07-03 2025-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -18.300 4.780.147 -0,38 42,50 -777.777 203.163.418
2025-05-20 2025-05-20 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -75.000 4.798.447 -1,54 33,40 -2.504.978 160.266.690
2025-05-20 2025-05-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -400 217.404 -0,18 33,75 -13.499 7.336.841
2025-05-20 2025-05-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -25.756 217.804 -10,57 33,32 -858.265 7.257.861
2025-05-20 2025-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -32.854 243.560 -11,89 33,84 -1.111.779 8.242.070
2025-05-20 2025-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 64.696 276.414 30,56
2025-04-24 2025-04-22 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -75.000 4.873.447 -1,52 34,11 -2.558.025 166.218.657
2025-03-27 2025-03-25 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -75.000 4.948.447 -1,49 36,87 -2.764.942 182.428.952
2025-02-27 2025-02-25 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -37.101 5.023.447 -0,73 33,79 -1.253.524 169.726.199
2025-02-27 2025-02-25 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -37.899 5.060.548 -0,74 33,36 -1.264.447 168.838.099
2025-02-19 2025-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -76 211.718 -0,04 36,56 -2.779 7.740.410
2025-02-19 2025-02-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -31.467 211.794 -12,94 36,14 -1.137.246 7.654.426
2025-02-19 2025-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -23.996 243.261 -8,98 34,90 -837.460 8.489.809
2025-02-19 2025-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 55.539 267.257 26,23
2025-01-30 2025-01-29 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -4.000 5.098.447 -0,08 36,82 -147.284 187.729.917
2025-01-30 2025-01-29 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -269.068 5.102.447 -5,01 36,34 -9.777.985 185.423.944
2025-01-30 2025-01-28 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -326.932 5.371.515 -5,74 36,29 -11.863.381 194.916.165
2024-12-27 2024-12-24 4 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 4.685.725 5.698.447 462,69
2024-12-27 2024-12-24 4 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -4.685.725 211.718 -95,68
2024-11-20 2024-11-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1.875 4.897.443 -0,04 22,76 -42.680 111.478.046
2024-11-20 2024-11-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -25.514 4.899.318 -0,52 22,39 -571.146 109.674.173
2024-11-19 2024-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -28.148 4.924.832 -0,57 23,72 -667.671 116.817.015
2024-11-19 2024-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 55.537 4.952.980 1,13
2024-08-20 2024-08-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11.197 4.897.443 -0,23 25,13 -281.367 123.066.866
2024-08-20 2024-08-19 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -16.192 4.897.443 -0,33 24,39 -394.889 119.438.350
2024-08-20 2024-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -28.148 4.924.832 -0,57 24,40 -686.811 120.165.901
2024-08-20 2024-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 55.537 4.952.980 1,13
2024-05-17 2024-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -30.748 4.897.443 -0,62 31,04 -954.418 152.016.631
2024-05-17 2024-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 60.667 4.928.191 1,25
2024-02-21 2024-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -47.922 4.867.524 -0,97 37,21 -1.783.178 181.120.568
2024-02-21 2024-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102.249 4.915.446 2,12
2023-11-20 2023-11-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -200 4.813.197 0,00 29,55 -5.910 142.229.971
2023-11-20 2023-11-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -51.352 4.813.397 -1,06 29,10 -1.494.128 140.049.636
2023-11-20 2023-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -50.697 4.864.749 -1,03 28,86 -1.463.115 140.396.656
2023-11-20 2023-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102.249 4.915.446 2,12
2023-08-18 2023-08-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -51.552 4.813.197 -1,06 28,59 -1.473.784 137.601.120
2023-08-18 2023-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -50.698 4.864.749 -1,03 29,80 -1.510.800 144.969.520
2023-08-18 2023-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102.250 4.915.447 2,12
2023-05-18 2023-05-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -51.552 4.813.197 -1,06 14,01 -722.218 67.430.483
2023-05-18 2023-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -50.697 4.864.749 -1,03 14,09 -714.321 68.544.313
2023-05-18 2023-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 102.249 4.915.446 2,12
2023-05-05 2023-05-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120.000 1.012.722 -10,59 14,18 -1.701.744 14.361.613
2023-04-07 2023-04-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120.000 1.132.722 -9,58 15,46 -1.855.656 17.516.186
2023-03-03 2023-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120.000 1.252.722 -8,74 10,96 -1.315.224 13.730.084
2023-02-21 2023-02-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -44.798 4.813.197 -0,92 12,70 -569.073 61.142.523
2023-02-21 2023-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -23.908 4.857.995 -0,49 12,64 -302.197 61.405.057
2023-02-21 2023-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68.706 4.881.903 1,43
2023-02-06 2023-02-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120.000 1.372.722 -8,04 11,01 -1.320.696 15.107.904
2023-01-06 2023-01-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -120.000 1.492.722 -7,44 7,67 -920.856 11.454.850
2022-12-21 2022-12-21 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale -200.000 995.686 -16,73
2022-11-18 2022-11-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale -34.640 4.813.197 -0,71 9,40 -325.606 45.242.608
2022-11-18 2022-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -34.066 4.847.837 -0,70 9,64 -328.396 46.733.149
2022-11-18 2022-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68.706 4.881.903 1,43
2022-08-18 2022-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -27.697 4.813.197 -0,57 11,08 -306.883 53.330.223
2022-08-18 2022-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68.705 4.840.894 1,44
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -61.182 428.274 -12,50
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2.394 26.336 -8,33
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.129 41.035 -11,11
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -23.759 4.772.189 -0,50 6,74 -160.136 32.164.554
2022-05-18 2022-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 68.705 4.795.948 1,45
2022-03-18 2022-03-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
A - Award 489.456 489.456
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2.394 28.730 -7,69
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.130 46.164 -10,00
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3.085 4.727.243 -0,07 8,84 -27.271 41.788.828
2022-02-18 2022-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7.524 4.730.328 0,16
2021-12-07 2021-12-03 4 BBIO BridgeBio Pharma, Inc.
Stock Option (right to buy)
A - Award 786.072 786.072
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2.394 31.124 -7,14
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.129 51.294 -9,09
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3.730 4.722.804 -0,08 47,25 -176.242 223.152.489
2021-11-18 2021-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7.523 4.726.534 0,16
2021-11-09 3/A LIAN LianBio
Ordinary Shares
5.002.792
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2.394 33.518 -6,67
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.129 56.423 -8,33
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3.730 4.719.011 -0,08 49,48 -184.560 233.496.664
2021-08-18 2021-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7.523 4.722.741 0,16
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -2.394 35.912 -6,25
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.130 61.552 -7,69
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -3.731 4.715.218 -0,08 53,66 -200.205 253.018.598
2021-05-18 2021-05-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 7.524 4.718.949 0,16
2021-02-18 2021-02-17 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes 16.000 4.711.425 0,34 62,50 1.000.000 294.464.062
2021-02-18 2021-02-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.129 66.682 -7,14
2021-02-18 2021-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -2.139 4.695.425 -0,05 64,98 -138.992 305.108.716
2021-02-18 2021-02-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 5.129 4.697.564 0,11
2021-02-12 2021-02-10 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
A - Award 38.306 38.306
2021-02-12 2021-02-10 4 BBIO BridgeBio Pharma, Inc.
Stock Option (Right to Buy)
A - Award 225.971 225.971
2021-02-12 2020-11-24 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 268.000 1.195.686 28,89
2021-02-12 2020-11-24 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -472.650 1.612.722 -22,67
2020-11-18 2020-11-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.129 71.811 -6,67
2020-11-18 2020-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -1.774 4.692.435 -0,04 44,33 -78.641 208.015.644
2020-11-18 2020-11-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 5.129 4.694.209 0,11
2020-08-18 2020-08-16 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
M - Exercise -5.129 76.940 -6,25
2020-08-18 2020-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
F - Taxes -1.774 4.689.080 -0,04 28,53 -50.612 133.779.452
2020-08-18 2020-08-16 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 5.129 4.690.854 0,11
2020-08-05 2020-08-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6.759 2.085.372 -0,32 27,36 -184.914 57.052.024
2020-08-05 2020-08-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7.184 2.092.131 -0,34 26,70 -191.846 55.869.522
2020-08-05 2020-08-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -3.040 2.099.315 -0,14 28,12 -85.498 59.041.975
2020-08-05 2020-08-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -63.017 2.102.355 -2,91 27,23 -1.715.808 57.242.291
2020-07-06 2020-07-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -56.445 2.165.372 -2,54 30,22 -1.706.022 65.447.286
2020-07-06 2020-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2.700 2.221.817 -0,12 32,42 -87.520 72.020.198
2020-07-06 2020-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -33.700 2.224.517 -1,49 31,67 -1.067.343 70.454.680
2020-07-06 2020-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -50.625 2.258.217 -2,19 30,63 -1.550.472 69.161.509
2020-06-10 2020-06-08 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -10.600 2.308.842 -0,46 30,01 -318.125 69.292.504
2020-06-05 2020-06-03 4 BBIO BridgeBio Pharma, Inc.
Restricted Stock Units
A - Award 82.069 82.069
2020-06-05 2020-06-03 4 BBIO BridgeBio Pharma, Inc.
Stock Option (Right to Buy)
A - Award 590.551 590.551
2020-06-05 2020-06-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5.930 2.319.442 -0,26 30,05 -178.173 69.690.186
2020-06-03 2020-06-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -8.709 2.325.372 -0,37 29,71 -258.711 69.077.966
2020-06-03 2020-06-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -71.291 2.334.081 -2,96 29,13 -2.076.678 67.990.846
2020-05-06 2020-05-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -34.834 2.405.372 -1,43 31,23 -1.088.012 75.129.870
2020-05-06 2020-05-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -44.766 2.440.206 -1,80 30,86 -1.381.470 75.304.269
2020-05-05 2020-05-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -33.974 2.484.972 -1,35 29,77 -1.011.494 73.984.077
2020-05-05 2020-05-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5.706 2.518.946 -0,23 29,13 -166.191 73.365.814
2020-05-05 2020-05-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -4.098 2.524.652 -0,16 29,78 -122.055 75.194.235
2020-05-05 2020-05-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -36.622 2.528.750 -1,43 29,06 -1.064.345 73.493.061
2020-04-09 2020-04-07 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1.805 2.565.372 -0,07 25,48 -45.983 65.353.878
2020-04-06 2020-04-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -100 2.567.177 0,00 25,10 -2.510 64.436.143
2020-04-06 2020-04-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -200 2.567.277 -0,01 25,09 -5.018 64.412.980
2020-04-03 2020-04-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -15.778 2.567.477 -0,61 25,04 -395.103 64.293.219
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -1.382 2.583.255 -0,05 28,20 -38.979 72.860.191
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12.976 2.584.637 -0,50 27,45 -356.252 70.960.433
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -20.040 2.597.613 -0,77 26,38 -528.623 68.520.875
2020-04-03 2020-04-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -27.719 2.617.653 -1,05 25,52 -707.508 66.813.760
2020-03-04 2020-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -201 2.645.372 -0,01 33,22 -6.677 87.880.581
2020-03-04 2020-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -12.090 2.645.573 -0,45 32,60 -394.105 86.239.330
2020-03-04 2020-03-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -7.756 2.657.663 -0,29 31,76 -246.365 84.419.336
2020-03-04 2020-03-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -995 2.665.419 -0,04 33,33 -33.159 88.828.020
2020-03-04 2020-03-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -59.305 2.666.414 -2,18 32,53 -1.929.411 86.748.313
2020-03-04 2020-03-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -39.653 2.725.719 -1,43 31,88 -1.264.312 86.907.915
2020-02-14 2019-12-30 5/A BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 66.730 4.685.725 1,44
2020-02-14 2019-12-30 5/A BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -400.375 0 -100,00
2020-02-13 2019-12-30 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift 66.730 4.685.365 1,44
2020-02-13 2019-12-30 5 BBIO BridgeBio Pharma, Inc.
Common Stock
G - Gift -400.375 0 -100,00
2020-02-07 2020-02-05 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -30.893 2.765.372 -1,10 34,87 -1.077.390 96.442.072
2020-02-05 2020-02-04 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -54.951 2.796.265 -1,93 34,55 -1.898.387 96.602.287
2020-02-05 2020-02-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -2.100 2.851.216 -0,07 35,20 -73.914 100.354.820
2020-02-05 2020-02-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -32.056 2.853.316 -1,11 34,92 -1.119.309 99.630.091
2020-01-06 2020-01-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -6.668 2.885.372 -0,23 32,88 -219.250 94.873.628
2020-01-06 2020-01-03 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -77.271 2.892.040 -2,60 32,14 -2.483.706 92.958.263
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -100 2.969.311 0,00 35,17 -3.517 104.430.668
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -5.077 2.969.411 -0,17 34,19 -173.560 101.511.097
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -19.793 2.974.488 -0,66 33,41 -661.342 99.386.270
2020-01-06 2020-01-02 4 BBIO BridgeBio Pharma, Inc.
Common Stock
S - Sale X -11.091 2.994.281 -0,37 32,55 -361.042 97.471.931
2019-07-08 2019-07-03 4 EIDX Eidos Therapeutics, Inc.
Common Stock
P - Purchase 882.353 24.575.501 3,72 29,90 26.382.796 734.819.768
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -1.907.102 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -2.744.459 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -927.686 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Management Incentive Units
M - Exercise -1.742.631 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Series B Units
M - Exercise -400.375 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Units
M - Exercise -906.905 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Units
M - Exercise -323.270 0 -100,00
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 927.686 927.686
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 400.375 400.375
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 1.907.102 7.624.367 33,36
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 2.744.459 5.717.265 92,32
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 1.742.631 2.972.806 141,66
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 906.905 1.230.175 280,54
2019-07-03 2019-07-01 4 BBIO BridgeBio Pharma, Inc.
Common Stock
M - Exercise 323.270 323.270
2019-06-27 3 BBIO BridgeBio Pharma, Inc.
No securities beneficially owned.
0
2019-05-29 2019-05-24 4 EIDX Eidos Therapeutics, Inc.
Common Stock
P - Purchase 1.103.848 23.693.148 4,89 25,93 28.622.779 614.363.328
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Series Seed Preferred Stock
C - Conversion -12.832.123 0 -100,00
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Series B Convertible Preferred Stock
C - Conversion -2.909.029 0 -100,00
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Series B Convertible Preferred Stock
X - Other 332.262 2.909.029 12,89
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Warrants
X - Other -332.262 0 -100,00
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Common Stock
P - Purchase 1.000.000 19.614.655 5,37 17,00 17.000.000 333.449.135
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Common Stock
F - Taxes -211.762 18.614.655 -1,12 17,00 -3.599.954 316.449.135
2018-06-22 2018-06-22 4 EIDX Eidos Therapeutics, Inc.
Common Stock
C - Conversion 18.826.417 18.826.417
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)